Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

188 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
SoundHound and White Castle Commit to Expand Successful Drive-Thru AI Partnership
BU
MYOVANT SCIENCES LTD. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events (form 8-K)
AQ
UpHealth Announces Fourth Quarter 2022 Financial Results
AQ
UpHealth Announces Third Quarter 2022 Financial Results
AQ
UPHEALTH : ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS - Form 8-K
PU
UPHEALTH, INC. : Material Modification to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
UpHealth Announces Results of First Annual Stockholder Meeting
GL
UpHealth Announces Results of First Annual Stockholder Meeting
AQ
Uphealth, Inc. Announces Executive Appointments
CI
UpHealth Solicits Proxies from Shareholders
CI
Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement
GL
Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement
PR
MYOVANT SCIENCES LTD. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
UBS West Coast Private Wealth Team Ranked Ninth Among Barron’s Top 100 Private Wealth Management Teams
BU
Transcript : Quest Diagnostics Incorporated, Q2 2022 Earnings Call, Jul 21, 2022
Jasper Mining Corporation Announces Executive Changes
CI
Quest Diagnostics : Names Sam Samad Executive Vice President and Chief Financial Officer - Form 8-K
PU
QUEST DIAGNOSTICS INC : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Quest Diagnostics Incorporated Names Sam Samad as Chief Financial Officer with Effect from July 11, 2022
CI
Quest Diagnostics Incorporated Names Sam Samad as Executive Vice President with Effect from July 11, 2022
CI
Transcript : Quest Diagnostics Incorporated Presents at UBS Global Healthcare Conference, May-24-2022 03:30 PM
Transcript : Quest Diagnostics Incorporated, Q1 2022 Earnings Call, Apr 21, 2022
Quest Diagnostics Incorporated Announces Mark Guinan Will Retire as Chief Financial Officer
CI
Quest Diagnostics Incorporated Announces Organizational Changes to Accelerate Growth and Drive Operational Excellence
CI
QUEST DIAGNOSTICS INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Transcript : Quest Diagnostics Incorporated, Q4 2021 Earnings Call, Feb 03, 2022
Quest Diagnostics Incorporated : Announces Leadership Succession Plan - Form 8-K
PU
QUEST DIAGNOSTICS INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Quest Diagnostics Announces Leadership Succession Plan
PR
Statement on PCAOB Budget and Accounting Support Fee Request for 2022
PU
Transcript : Quest Diagnostics Incorporated Presents at 30th Annual Credit Suisse Healthcare Conference, Nov-09-2021 09:40 AM
MYOVANT SCIENCES LTD. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
Statement on PCAOB Rule 6100 to Fulfill Obligations under the HFCAA
PU
Quest Diagnostics To Speak At The Credit Suisse 30™ Annual Healthcare Conference
PR
Transcript : Quest Diagnostics Incorporated, Q3 2021 Earnings Call, Oct 21, 2021
Transcript : Quest Diagnostics Incorporated, Q2 2021 Earnings Call, Jul 22, 2021
Myovant Sciences : Annual Report (SEC Filing - 10-K)
PU
Transcript : Quest Diagnostics Incorporated Presents at BofA Securities 2021 Virtual Health Care Conference, May-11-2021 12:30 PM
Quest Diagnostics : To Speak At BofA Securities 2021 Virtual Healthcare Conference
PR
Transcript : Quest Diagnostics Incorporated, Q1 2021 Earnings Call, Apr 22, 2021
Intercontinental Exchange : ICE announces Exchange Members and Clearing Members approved to trade and clear ICE Futures Abu Dhabi markets
BU
Quest Diagnostics Incorporated : By the Numbers - Mark Guinan
PU
Transcript : Quest Diagnostics Incorporated - Analyst/Investor Day
Transcript : Quest Diagnostics Incorporated Presents at 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference, Feb-24-2021 01:30 PM
Quest Diagnostics : To Speak At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference
PR
Quest Diagnostics : to Host Virtual Investor Day On March 11, 2021
PR
Transcript : Quest Diagnostics Incorporated, Q4 2020 Earnings Call, Feb 04, 2021
Quest raises profit forecast as COVID-19 tests demand to jump
RE
Transcript : Quest Diagnostics Incorporated, Q3 2020 Earnings Call, Oct 22, 2020
MYOVANT SCIENCES LTD. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
No results for this search
  1. Stock Market
  2. Advanced search
  3. Mark Guinan
  4. News